Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
1.060
0.00 (0.00%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Oncolytics Biotech Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 114 | 70 | 100 | 96 | 76 | 103 | |
| Market Cap Growth | 100.11% | -29.42% | 3.71% | 25.79% | -25.81% | -17.82% | |
| Enterprise Value | 106 | 57 | 71 | 73 | 39 | 83 | |
| Last Close Price | 1.06 | 0.91 | 1.35 | 1.63 | 1.39 | 2.38 | |
| PB Ratio | 1381.54 | 16.94 | 4.78 | 4.91 | 2.68 | 5.31 | |
| P/TBV Ratio | 1381.54 | 16.94 | 4.78 | 4.91 | 2.68 | 5.31 | |
| Debt / Equity Ratio | 7.26 | 0.18 | 0.02 | 0.01 | 0.02 | 0.02 | |
| Net Debt / Equity Ratio | -100.15 | -2.49 | -1.25 | -1.20 | -1.12 | -1.25 | |
| Net Debt / EBITDA Ratio | 0.33 | 0.43 | 1.02 | 1.18 | 1.56 | 1.22 | |
| Net Debt / FCF Ratio | 0.44 | 0.55 | 1.21 | 1.36 | 1.79 | 1.40 | |
| Quick Ratio | 1.62 | 2.39 | 8.24 | 8.15 | 15.37 | 11.56 | |
| Current Ratio | 1.84 | 2.82 | 9.01 | 9.05 | 16.69 | 12.45 | |
| Return on Equity (ROE) | -769.06% | -189.05% | -102.66% | -79.34% | -86.45% | -182.63% | |
| Return on Assets (ROA) | -111.21% | -74.11% | -55.46% | -40.44% | -40.88% | -58.93% | |
| Return on Capital Employed (ROCE) | -472.60% | -259.10% | -97.70% | -80.60% | -60.70% | -80.50% | |
| Earnings Yield | -22.20% | -31.29% | -21.06% | -19.07% | -27.18% | -17.13% | |
| FCF Yield | -17.08% | -26.85% | -21.59% | -17.98% | -23.47% | -16.82% | |
| Buyback Yield / Dilution | -17.39% | -13.10% | -16.53% | -8.44% | -32.66% | -82.22% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.